CTOs on the Move

Cardurion

www.cardurion.com

 
Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases. Founded by physician-scientist, Michael E. Mendelsohn, M.D., and built by a team of physician-scientists and industry leaders with extensive experience in cardiovascular disease, drug development and business development, Cardurion Pharmaceuticals is pursuing unique drug discovery and development programs to target major unmet needs in cardiovascular medicine. Cardurion Pharmaceuticals has facilities in Burlington, Massachusetts and Shonan, Japan.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cardurion.com
  • 78 Blanchard Road Suite 200
    Burlington, MA USA 01803
  • Phone: 617.863.8088

Executives

Name Title Contact Details

Similar Companies

Cerevel

Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson`s, Alzheimer`s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.

Zyber Pharmaceuticals

Zyber Pharmaceuticals is a Lafayette, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Critical Outcome Technologies

Critical Outcome Technologies Inc. is a London, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Almirall

With over 1,975 employees, it has a presence, through its 13 affiliates in Europe and United States.

United Drugs

United Drugs is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.